The National Ataxia Foundation (NAF) is an organization devoted to raising awareness, supporting families, and funding research for Ataxia, a rare and progressive neurological condition that impairs ...
(Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the poster presentation of ...
Please provide your email address to receive an email when new articles are posted on . Vatiquinone inhibits 15-Lipoxygenase, which regulates the pathways that Friedreich’s ataxia disrupts. PTC ...
Daniel Fraser, 36, was diagnosed with Friedreich’s Ataxia, a progressive disease that causes mobility, speech issues and ...
Alex Parker spoke with neurologist Dr. Theresa Zesiewicz to discuss Spinocerebellar Ataxia (SCA), a rare genetic disorder that has no cure. Dr. Zesiewicz explained the daily struggles families face, ...
This media is in the public domain (free of copyright restrictions). You can copy, modify, and distribute this work without contacting the Smithsonian. For more information, visit the Smithsonian's ...
Monthly infusions of an investigational product that encapsulates dexamethasone sodium phosphate into autologous erythrocytes (EryDex) appeared safe but did not significantly improve neurological ...
Dr. Anna K. Bonkhoff (Neurology): A 69-year-old man was admitted to this hospital because of headache and ataxia. The patient had a history of systemic diffuse large B-cell lymphoma (DLBCL), which had ...
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting Quince Therapeutics, Inc. (Nasdaq: QNCX), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback